05 JUL 2022
World-first treatment changes outlook for SMA babies
Babies diagnosed with Spinal Muscular Atrophy (SMA) at birth who received life-changing gene therapy...
29 JUN 2022
An alliance to revolutionise paediatric care
Unparalleled collaboration, world-first precision medicine and more young lives saved – the Luminesce...
20 JUN 2022
CMRI represented at Bio International Convention
NSW’s international reputation in advanced therapeutics was the topic for discussion when Children’s...
19 JUN 2022
$270 million to accelerate med tech innovation
NSW will be at the forefront of cutting edge health treatments as part of a $270 million boost to biomedical...
17 JUN 2022
What medtech start-ups need to know about protecting intellectual property
The NSW Health Commercialisation Training Program includes a one-day seminar to help start-ups understand...
16 JUN 2022
NSW medtech takes centre stage at San Diego BIO 2022
NSW’s leading research and medtech capabilities will be showcased to the world at one of the largest...
10 JUN 2022
Budget investment to accelerate RNA R&D
The NSW Government will accelerate the translation of local RNA research into new products, services...
26 MAY 2022
ZERO ramps up
The highly successful Zero Childhood Cancer program (ZERO) is opening its doors to all children with...
19 MAY 2022
Banking on early diagnosis and treatment
“By discovering novel markers and mechanisms for disease, we have the opportunity to act early and prevent...
11 MAY 2022
Bringing Novavax to Australia’s COVID-19 vaccine rollout
Sydney-based sister companies Biointelect and Biocelect have been a driving force in the rollout of the Novavax...